Schonfeld Strategic Advisors LLC Silence Therapeutics PLC Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 123,200 shares of SLN stock, worth $554,400. This represents 0.01% of its overall portfolio holdings.
Number of Shares
123,200
Previous 166,000
25.78%
Holding current value
$554,400
Previous $3.02 Million
71.94%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding SLN
# of Institutions
66Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$13.7 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$12.7 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$10.8 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.35 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$7.48 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $161M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...